Active Fine Chemicals Limited

ACTIVEFINE

BD0483ACFCH9

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
12.2 ^BDT	-2.40%		-15.28%	-36.79%

2022	Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2022	CI
2022	Active Fine Chemicals Limited Has Recommends Cash Dividend for the Year Ended on June 30, 2022	CI

Active Fine Chemicals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021

October 31, 2021 at 11:24 am EDT

The Board of Directors of Active Fine Chemicals Limited has recommended 0.50% Cash dividend (other than Sponsors and Directors) for the year ended on June 30, 2021.

Latest news about Active Fine Chemicals Limited

Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-12-15	CI
Active Fine Chemicals Limited Has Recommends Cash Dividend for the Year Ended on June 30, 2022	22-10-30	CI
Active Fine Chemicals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	21-12-05	CI
Active Fine Chemicals Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-12-02	CI
Active Fine Chemicals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021	21-10-31	CI
Active Fine Chemicals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019	19-12-01	CI
Active Fine Chemicals Ltd. Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-14	CI
Active Fine Chemicals Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2018	19-01-14	CI
Active Fine Chemicals Ltd. Announces Earnings Results for the Year Ended June 30, 2018	18-10-28	CI
Active Fine Chemicals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2018	18-10-14	CI
Active Fine Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	18-04-25	CI
Active Fine Chemicals Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 2017	18-01-29	CI
Active Fine Chemicals Limited Reports un-audited Earnings Results for the first quarter Ended September 30, 2017	17-11-14	CI
Active Fine Chemicals Limited Reports Earnings Results for the Year Ended June 30, 2017	17-10-28	CI
Active Fine Chemicals Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 2017	17-04-26	CI
Active Fine Chemicals Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 2016	17-01-28	CI
Active Fine Chemicals Ltd. Announces Un-Audited Earnings Results for the First Quarter Ended September 30, 2016	16-11-14	CI
Active Fine Chemicals Ltd. Reports Unaudited Earnings Results for the Three Months and Six Months Ended June 30, 2012	12-07-18	CI

Chart Active Fine Chemicals Limited

Duration

Period

More charts

Active Fine Chemicals Limited is a Bangladesh-based manufacturer of active pharmaceutical ingredients (APIs) and lab reagents. The Company is primarily engaged in the producing bulk drugs/ API and different laboratory reagents. Its APIs include Azithromycin Dihydrate; Erythromycin Ethyl Succinate; Erythromycin Stearate; Esomeprazole Magnesium Trihydrate; Esomeprazole Magnesium Pellets; Pantoprazole Sodium Sesquihydrate; Fluconazole; Atorvastatin Calcium; Cetirizine Hydrochloride; Fexofenadine Hydrochloride; Desloratadine; Venlafaxine HCL; Cefixime Trihydrate, Cefuroxime Axetil, Metformin Hydrochloride; Sitagliptin Phosphate Monohydrate; Vidagliptin; Gliclazide; Glimepiride; Pregabalin; Losartan Potassium; Amlodipine Besylate; Etoricoxib; Ketorolac Tromethamine and Ticagrelor. The Companyâs laboratory Reagent category includes products, such as HPLC Grade solvents, Solvents and Powder reagents. Its factory is located in West Muktarpur, Munshiganj, Bangladesh.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ACTIVE FINE CHEMICALS LIMITED	-36.79%	26.66M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B